Welcome to our dedicated page for Amphenol SEC filings (Ticker: APH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Amphenol Corporation (NYSE: APH) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret complex documents. Amphenol uses Form 8-K current reports extensively to announce material events, including acquisitions, financing arrangements and governance changes.
Recent APH filings include Form 8-K reports detailing the completion of the acquisition of CommScope’s Connectivity and Cable Solutions business for approximately $10.5 billion in cash, the entry into three-year and 364-day unsecured delayed draw term loan credit agreements intended to help finance that acquisition, and the issuance of multiple series of senior notes with maturities ranging from 2027 to 2055. Other 8-Ks cover topics such as quarterly financial results, the acquisition of Trexon, the acquisition of Rochester Sensors, and the appointment of Sanjiv Lamba to Amphenol’s board of directors.
On this page, you can review Amphenol’s current reports on Form 8-K, as well as its annual reports on Form 10-K, quarterly reports on Form 10-Q and other registered securities documents when available. These filings provide insight into Amphenol’s interconnect, sensor and cable businesses, its capital structure, and its acquisition and financing strategies.
Stock Titan enhances these documents with AI-powered summaries that highlight key terms, such as acquisition consideration, financing amounts, segment classification for acquired businesses, and significant changes in governance or capital markets activity. Users can also quickly locate information about Amphenol’s registered securities, including its Class A common stock and listed senior notes, and monitor new filings as they are posted to EDGAR.
For investors analyzing APH stock, this filings page offers a structured way to review Amphenol’s regulatory history, understand the details behind major transactions like the CCS acquisition and Trexon purchase, and see how the company discloses risks, non-GAAP measures and other important information in its SEC reports.
Form 144 filed for Amphenol Corporation (APH) shows a proposed sale of 100,000 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $11,042,030.00 and reported shares outstanding of 1,220,921,111. The filing states the securities were acquired by exercise of options under a registered plan on 08/25/2025 and payment was in cash. The document also lists a sale by David Silverman of 100,000 common shares on 05/30/2025 that generated $8,909,350.00 in gross proceeds. The filer affirms no undisclosed material adverse information and includes the standard Rule 144 representations and signature warning regarding intentional misstatements.
Form 144 notice for Amphenol Corporation (APH) reporting a proposed sale of 40,076 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $4,430,602.18. The filing shows those shares were acquired and paid for on 08/25/2025 via exercise of options under a registered plan and paid in cash. The form also discloses a prior sale by the same person, Craig Lampo, of 199,848 common shares on 08/22/2025 generating gross proceeds of $22,069,674.29. The filer certifies there is no undisclosed material adverse information and includes the standard Rule 144 and 10b5-1 representations.
Craig A. Lampo, Senior VP & CFO of Amphenol Corporation (APH), reported transactions on 08/22/2025. He exercised stock options totaling 199,848 shares at an exercise price of $21.995 per share and immediately sold 199,848 shares at a weighted average sale price of $110.4323 per share (trades ranged from $109.55 to $110.94). The Form 4 discloses the option exercise date as 08/22/2025 with the underlying option grant dated 05/18/2019 and an expiration of 05/18/2028.
After these reported transactions, the filing shows the reporting person beneficially owned 325,543 shares directly or indirectly, including specific indirect holdings: 58,116 shares in a 2025 GRAT #1, 74,305 in a 2024 GRAT #1, 160,000 in a 2024 GRAT #2, and 39,884 in the Lampo Family Trust. The filing was signed by a POA on 08/25/2025.
Amphenol Corporation (APH) Form 144 shows a proposed sale of 199,848 common shares through Morgan Stanley Smith Barney on the NYSE with an approximate sale date of 08/22/2025. The filing reports an aggregate market value of $22,069,674.29 and total shares outstanding of 1,220,921,111. The shares were recorded as acquired on 08/22/2025 by exercise of options under a registered plan and paid for in cash the same date. The filing notes "Nothing to Report" for securities sold in the past three months. Filer identity fields (CIK/CCC and contact details) are not populated in the provided content.
Lance E. D'Amico, Sr. VP, Secretary & General Counsel of Amphenol Corporation (APH), reported multiple transactions on 08/18/2025. The filing shows exercises of stock options and contemporaneous open-market sales. The reporting person exercised a 100,000-share option at an exercise price of $22.5525 and a 30,000-share option at $22.3725. On the same date the filing reports sales of 100,000 and 30,000 Class A common shares at weighted-average prices of approximately $110.6003 and $110.8083, respectively. The Form 4 indicates various direct and indirect beneficial ownership figures after these transactions, including a reported 25,000 shares indirectly held in a 2025 GRAT.
Amphenol Corporation (APH) Form 144 notifies the SEC of a proposed sale of 30,000 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $3,324,249.00. The filing states the shares were acquired and are to be sold on 08/18/2025 via exercise of options under a registered plan and paid for in cash. The issuer's total shares outstanding listed in the form are 1,220,921,111, and there were no reported sales in the past three months for this account. The filer represents there is no undisclosed material adverse information.
Amphenol Corporation (APH) filed a Form 144 reporting a proposed sale of 100,000 common shares by a person who acquired those shares via exercise of options under a registered plan on 08/18/2025. The filing shows the sale is to be executed through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $11,060,030.00 and a reported outstanding share count of 1,220,921,111. The filer states no securities were sold by the same person in the past three months and certifies lack of undisclosed material adverse information.
Amphenol Corp (APH) insider William J. Doherty, President of the CS Division, reported option exercises and immediate sales of Class A common stock. The form shows exercises of stock options with an exercise price of $22.5525 that were converted into 113,000 shares on 08/08/2025 and again on 08/11/2025, with the options listed as exercisable since 05/21/2021 and expiring 05/21/2030.
On each date the acquired shares were sold: the 08/08/2025 sale reported a weighted-average price of $108.8916 (trades ranged $108.7550–$109.1900) and the 08/11/2025 sale reported a weighted-average price of $110.2906 (trades ranged $110.00–$110.9100). After the reported sales the filing shows 0 shares held by the reporting person. The form is signed by a POA, Lance E. D'Amico.
Michael R. Ivas, Amphenol Corporation's VP & Corporate Controller, reported an option exercise and an immediate sale of the resulting shares on 08/08/2025. He exercised 50,000 stock options at an exercise price of $18.23 and acquired 50,000 Class A shares, then sold 50,000 Class A shares at a weighted average sale price of $110.0164 (executed in multiple trades between $110.00 and $110.08). After these transactions the filing shows 152,412 shares beneficially owned directly by the reporting person and 0 stock options remaining. The filing also lists indirect holdings of 2,995 shares by children and 1,700 shares by spouse. The report documents conversion/exercise activity and a contemporaneous sale, reducing derivative holdings to zero while leaving a material direct ownership stake.
Amphenol Corporation (APH) filed a Form 144 reporting a proposed Rule 144 sale of 113,000 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $12,462,837.80 and 1,220,921,111 shares outstanding. The filing shows these shares were acquired on 08/11/2025 by exercise of options under a registered plan and payment was made in cash on the same date.
The filing also lists recent sales by the named seller, William Doherty: 113,000 shares sold on 08/08/2025 for $12,304,750.80 and 160,000 shares sold on 05/30/2025 for $14,326,512.00, totaling 273,000 shares and $26,631,262.80 in gross proceeds during the past three months. The notice includes the seller's representation that no undisclosed material adverse information exists.
FAQ
What is the current stock price of Amphenol (APH)?
What is the market cap of Amphenol (APH)?
